6-Shogaol reduces progression of experimental endometriosis in vivo and in vitro via regulation of VGEF and inhibition of COX-2 and PGE2-mediated inflammatory responses

다국어 초록 (Multilingual Abstract)

Endometriosis (EM) is one of the most common gynaecological disorder affecting women in their reproductive age. Mechanisms involved in the pathogenesis of EM remains poorly understood, however inflammatory responses have been reported to be significantly involved. The efficacy of 6-shogaol on proliferation of endometriotic lesions and inflammatory pathways in experimentally-induced EM model was explored in this study. EM was stimulated in Sprague-Dawley rats by implantation of autologous endometrium onto the peritoneum abdominal wall. Separate groups were treated with 6-shogaol (50, 100 or 150 mg/kg b.wt/day) via oral gavage for one month period. Gestrinone (GTN) group received GTN (0.5 mg/kg/day) as positive control. Five weeks after implantation, the spherical volume of ecto-uterine tissues was determined. Treatment with 6-shogaol significantly reduced the implant size. Histological analysis reported atrophy and regression of the lesions. 6-shogaol administration effectively down-regulated NF-κB signaling, VEGF and VEGFR-2 (Flk-1) expression in the endometriotic lesions. Excess production of IL-1 and IL-6 (pro-inflammatory cytokines), PGE2 and nitric oxide (NO) were reduced. Overall, the results of the study reveal the efficacy of 6-shogaol against endometriosis via effectively suppressing proliferation of the lesions and modulating angiogenesis and COX-2/NF-κB-mediated inflammatory cascades.

목차 (Table of Contents)

• INTRODUCTION
• METHODS
• RESULTS
• DISCUSSION
• CONCLUSION

참고문헌 (Reference)

1 McLaren J., "Vascular endothelial growth factor and endometriotic angiogenesis" 6 : 45-55, 2000

2 Groothuis PG, "Vascular development in endometriosis" 8 : 147-156, 2005

3 Kiriakidis S, "VEGF expression in human macrophages is NF-kappaBdependent : studies using adenoviruses expressing the endogenous NF-kappaB inhibitor IkappaBalpha and a kinase-defective form of the IkappaB kinase 2" 116 : 665-674, 2003

4 Tamura M, "Up-regulation of cyclooxygenase-2 expression and prostaglandin synthesis in endometrial stromal cells by malignant endometrial epithelial cells. A paracrine effect mediated by prostaglandin E2 and nuclear factor-kappa B" 277 : 26208-26216, 2002

5 Guo SW, "Two unsuccessful clinical trials on endometriosis and a few lessons learned" 64 : 24-35, 2007

6 Cao WG, "Tumour necrosis factor-alpha up-regulates macrophage migration inhibitory factor expression in endometrial stromal cells via the nuclear transcription factor NF-kappaB" 21 : 421-428, 2006

7 Kim YA, "Tumor necrosis factor-alpha-induced cyclooxygenase-2 overexpression in eutopic endometrium of women with endometriosis by stromal cell culture through nuclear factor-kappaB activation" 54 : 625-630, 2009

8 Falconer H, "Treatment with anti-TNF monoclonal antibody (c5N) reduces the extent of induced endometriosis in the baboon" 21 : 1856-1862, 2006

9 Farina AR, "Transcriptional up-regulation of matrix metalloproteinase-9expression during spontaneous epithelial to neuroblast phenotype conversion by SK-N-SH neuroblastoma cells, involved in enhanced invasivity, depends upon GT-box and nuclear factor kappaB elements" 10 : 353-367, 1999

10 Akira S, "Toll-like receptors: critical proteins linking innate and acquired immunity" 2 : 675-680, 2001

11 Bourlev V, "The relationship between microvessel density, proliferative activity and expression of vascular endothelial growth factor-A and its receptors in eutopic endometrium and endometriotic lesions" 132 : 501-509, 2006

12 Yildirim G, "The effects of letrozole and melatonin on surgically induced endometriosis in a rat model : a preliminary study" 93 : 1787-1792, 2010

13 Bruner KL, "Suppression of matrix metalloproteinases inhibits establishment of ectopic lesions by human endometrium in nude mice" 99 : 2851-2857, 1997

14 Vernon MW, "Studies on the surgical induction of endometriosis in the rat" 44 : 684-694, 1985

15 Cao WG, "Stimulation of macrophage migration inhibitory factor expression in endometrial stromal cells by interleukin 1, beta involving the nuclear transcription factor NFkappaB" 73 : 565-570, 2005

16 Ali BH, "Some phytochemical, pharmacological and toxicological properties of ginger(Zingiber officinale Roscoe) : a review of recent research" 46 : 409-420, 2008

17 Laschke MW, "Selective cyclo-oxygenase-2 inhibition induces regression of autologous endometrial grafts by down-regulation of vascular endothelial growth factor-mediated angiogenesis and stimulation of caspase-3-dependent apoptosis" 87 : 163-171, 2007

18 Harada T, "Role of cytokines in endometriosis" 76 : 1-10, 2001

19 Ergenoğlu AM, "Regression of endometrial implants by resveratrol in an experimentally induced endometriosis model in rats" 20 : 1230-1236, 2013

20 Han S, "RU486-induced growth inhibition of human endometrial cells involves the nuclear factor-kappa B signaling pathway" 88 : 713-719, 2003

21 Park JY, "Prostaglandin E2 synthesis and secretion: the role of PGE2 synthases" 119 : 229-240, 2006

22 Viatour P, "Phosphorylation of NFkappaB and IkappaB proteins : implications in cancer and inflammation" 30 : 43-52, 2005

23 Karin M, "Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity" 18 : 621-663, 2000

24 Suekawa M, "Pharmacological studies on ginger. I. Pharmacological actions of pungent constitutents, (6)-gingerol and (6)-shogaol" 7 : 836-848, 1984

25 Lebovic DI, "Peroxisome proliferator-activated receptor-gamma induces regression of endometrial explants in a rat model of endometriosis" 82 (82): 1008-1013, 2004

26 Van Langendonckt A, "Oxidative stress and peritoneal endometriosis" 77 : 861-870, 2002

27 González-Ramos R, "Nuclear factor-kappa B is constitutively activated in peritoneal endometriosis" 13 : 503-509, 2007

28 Wu MY, "Nitric oxide synthesis is increased in the endometrial tissue of women with endometriosis" 18 : 2668-2671, 2003

29 Lin YJ, "Neutrophils and macrophages promote angiogenesis in the early stage of endometriosis in a mouse model" 147 : 1278-1286, 2006

30 Tariverdian N, "Neuroendocrine-immune disequilibrium and endometriosis: an interdisciplinary approach" 29 : 193-210, 2007

31 Santanam N, "Macrophages, oxidation, and endometriosis" 955 : 183-198, 2002

32 Chen SU, "Lysophosphatidic acid mediates interleukin-8 expression in human endometrial stromal cells through its receptor and nuclear factor-kappaB-dependent pathway: a possible role in angiogenesis of endometrium and placenta" 149 : 5888-5896, 2008

33 González-Ramos R, "Involvement of the nuclear factor-κB pathway in the pathogenesis of endometriosis" 94 : 1985-1994, 2010

34 Tamura M, "Interleukin-1beta elevates cyclooxygenase-2 protein level and enzyme activity via increasing its mRNA stability in human endometrial stromal cells : an effect mediated by extracellularly regulated kinases 1 and 2" 87 : 3263-3273, 2002

35 Perkins ND, "Integrating cell-signalling pathways with NF-kappaB and IKK function" 8 : 49-62, 2007

36 Ruhland B1, "Innovations in conservative endometriosis treatment : an updated review" 63 : 247-259, 2011

37 Park KK, "Inhibitory effects of [6]-gingerol, a major pungent principle of ginger, on phorbol esterinduced inflammation, epidermal ornithine decarboxylase activity and skin tumor promotion in ICR mice" 129 : 139-144, 1998

38 Zhang Y, "Inhibitory effect of curcumin on angiogenesis in ectopic endometrium of rats with experimental endometriosis" 27 : 87-94, 2011

39 Boulanger D, "Increased nuclear factor kappaB activity in milk cells of mastitis-affected cows" 86 : 1259-1267, 2003

40 Chishima F, "Increased expression of cyclooxygenase-2 in local lesions of endometriosis patients" 48 : 50-56, 2002

41 Lousse JC, "Increased activation of nuclear factor-kappa B (NF-kappaB) in isolated peritoneal macrophages of patients with endometriosis" 90 : 217-220, 2008

42 Machado DE, "Higher expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 (Flk-1) and metalloproteinase-9 (MMP-9) in a rat model of peritoneal endometriosis is similar to cancer diseases" 29 : 4-, 2010

43 National Research Council, "Guide for the care and use of laboratory animals" National Academy Press 2011

44 Ishiguro K, "Ginger ingredients reduce viability of gastric cancer cells via distinct mechanisms" 362 : 218-223, 2007

45 Chilov D, "Genomic organization of human and mouse genes for vascular endothelial growth factor C" 272 : 25176-25183, 1997

46 Wang HB, "Expression of vascular endothelial growth factor receptors in the ectopic and eutopic endometrium of women with endometriosis" 85 : 1555-1559, 2005

47 Machado DE, "Euterpe oleracea extract (Açaí) is a promising novel pharmacological therapeutic treatment for experimental endometriosis" 11 : e0166059-, 2016

48 Eskenazi B, "Epidemiology of endometriosis" 24 : 235-258, 1997

49 Wu MH, "Endometriosis: disease pathophysiology and the role of prostaglandins" 9 : 1-20, 2007

50 Giudice LC, "Endometriosis" 364 : 1789-1799, 2004

51 Mihalyi A, "Emerging drugs in endometriosis" 11 : 503-524, 2006

52 Olivares C, "Effects of a selective cyclooxygenase-2 inhibitor on endometrial epithelial cells from patients with endometriosis" 23 : 2701-2708, 2008

53 Kennedy S, "ESHRE guideline for the diagnosis and treatment of endometriosis" 20 : 2698-2704, 2005

54 Wu MH, "Distinct mechanisms regulate cyclooxygenase-1 and -2 in peritoneal macrophages of women with and without endometriosis" 8 : 1103-1110, 2002

55 Tang Q, "Combination use of ferulic acid, ligustrazine and tetrahydropalmatine inhibits the growth of ectopic endometrial tissue : a multi-target therapy for endometriosis rats" 151 : 1218-1225, 2014

56 Celik O, "Combating endometriosis by blocking proteasome and nuclear factor-kappaB pathways" 23 : 2458-2465, 2008

57 Hoffmann A, "Circuitry of nuclear factor kappaB signaling" 210 : 171-186, 2006

58 Shukla Y, "Cancer preventive properties of ginger: a brief review" 45 : 683-690, 2007

59 Ebert AD, "Aromatase inhibitors and cyclooxygenase-2 (COX-2) inhibitors in endometriosis: new questions--old answers?" 122 : 144-150, 2005

60 Taylor RN, "Angiogenic factors in endometriosis" 955 : 89-100, 2002

61 Becker CM, "Angiogenesis and antiangiogenic therapy in endometriosis" 74 : 121-130, 2007

62 Machado DE, "A selective cyclooxygenase-2inhibitor suppresses the growth of endometriosis with an antiangiogenic effect in a rat model" 93 : 2674-2679, 2010

63 Bak MJ, "6-shogaol-rich extract from ginger up-regulates the antioxidant defense systems in cells and mice" 17 : 8037-8055, 2012

64 Seow SLS, "6-shogaol, a neuroactive compound of ginger (jahe gajah) induced neuritogenic activity via NGF responsive pathways in PC-12 cells" 17 : 334-, 2017

65 Park G, "6-Shogaol, an active compound of ginger, alleviates allergic dermatitis-like skin lesions via cytokine inhibition by activating the Nrf2 pathway" 310 : 51-59, 2016

66 Ray A, "6-Shogaol inhibits breast cancer cells and stem cell-like spheroids by modulation of notch signaling pathway and induction of autophagic cell death" 10 : e0137614-, 2015

67 Han Q, "6-Shogaol attenuates LPS-induced inflammation in BV2 microglia cells by activating PPAR-" 8 : 42001-42006, 2017